Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. (SHA:603707)
China flag China · Delayed Price · Currency is CNY
10.33
+0.02 (0.19%)
Oct 14, 2025, 11:29 AM CST

SHA:603707 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
707.39826.14-189.451,0911,059806.12
Upgrade
Depreciation & Amortization
216.84174.85154.06139.5393.2284.55
Upgrade
Other Amortization
0.190.190.190.190.20.23
Upgrade
Loss (Gain) From Sale of Assets
0.180.040.040.111.030.22
Upgrade
Asset Writedown & Restructuring Costs
8.658.640.0310.227.2352
Upgrade
Loss (Gain) From Sale of Investments
-26.18-7.8185.58-24.1-24.57-10.55
Upgrade
Provision & Write-off of Bad Debts
9.258.22-3.05-0.423.22-
Upgrade
Other Operating Activities
-158.17-34.841,241-99.4387.4755.67
Upgrade
Change in Accounts Receivable
-75.2-13.19163.36-1,456-148.2-345.27
Upgrade
Change in Inventory
438.54598.72213.28-731.57-444.05-1,223
Upgrade
Change in Accounts Payable
13.94-185.77224.661,71046.8211.23
Upgrade
Change in Other Net Operating Assets
58.05-20.08-21.25-15.113.4511.51
Upgrade
Operating Cash Flow
1,3051,5011,619595.45683.63-565.85
Upgrade
Operating Cash Flow Growth
-18.18%-7.28%171.92%-12.90%--
Upgrade
Capital Expenditures
-587.83-506.82-419.07-470.08-440.76-294.36
Upgrade
Sale of Property, Plant & Equipment
0.100.150.110.540.12
Upgrade
Cash Acquisitions
-----13.87-
Upgrade
Investment in Securities
1,114-459.05-757.4736.06610.72-887.57
Upgrade
Other Investing Activities
85.9955.1414.3433.4213.519.03
Upgrade
Investing Cash Flow
612.06-910.73-1,162-400.5170.14-1,173
Upgrade
Short-Term Debt Issued
-----3,073
Upgrade
Long-Term Debt Issued
-1,8663,3993,3582,1261,266
Upgrade
Total Debt Issued
1,4221,8663,3993,3582,1264,339
Upgrade
Short-Term Debt Repaid
------2,311
Upgrade
Long-Term Debt Repaid
--2,373-3,094-3,441-2,687-
Upgrade
Total Debt Repaid
-2,459-2,373-3,094-3,441-2,687-2,311
Upgrade
Net Debt Issued (Repaid)
-1,037-506.04305.39-83.41-560.942,028
Upgrade
Issuance of Common Stock
---0.3741.17227.35
Upgrade
Repurchase of Common Stock
-10.33-12.04-5.72-1.13-0.87-1.04
Upgrade
Common Dividends Paid
-378.84-213.19-248.47-226.65-191.75-261.21
Upgrade
Other Financing Activities
-----200-19.57
Upgrade
Financing Cash Flow
-1,426-731.2851.2-310.81-912.391,973
Upgrade
Foreign Exchange Rate Adjustments
55.2-16.783.18-16.1120.05-9.88
Upgrade
Net Cash Flow
546.13-157.49591.51-131.97-38.57224.78
Upgrade
Free Cash Flow
717.38994.411,200125.37242.87-860.21
Upgrade
Free Cash Flow Growth
-27.58%-17.14%857.27%-48.38%--
Upgrade
Free Cash Flow Margin
19.07%25.34%30.53%3.38%6.59%-29.51%
Upgrade
Free Cash Flow Per Share
0.440.600.760.080.15-0.54
Upgrade
Cash Income Tax Paid
-104.54108.8691.0146.06-5.82
Upgrade
Levered Free Cash Flow
220.9498.141,279-540.91-186.72-1,220
Upgrade
Unlevered Free Cash Flow
256.95545.431,330-504.75-129.08-1,184
Upgrade
Change in Working Capital
547.05525.78330.47-521.49-543.45-1,554
Upgrade
Updated Oct 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.